XML 91 R76.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions - Summary of Assets and Liabilities Acquired (Details) - USD ($)
$ in Millions
 2 Months Ended 12 Months Ended
Jul. 19, 2022
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets, Gross [Abstract]          
Goodwill     $ 1,589.3 $ 1,463.3 $ 1,468.9
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]          
Payments to Acquire Businesses, Net of Cash Acquired [1]     $ 198.2 $ 5.2 $ 65.6
Developed Technology          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]          
Weighted avg. useful life remaining at December 31, 2022     13 years    
BioPhero          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents $ 10.0        
Finite-Lived Intangible Assets, Gross [Abstract]          
Goodwill 130.7        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other 3.4        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill 220.9        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities 16.6        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other 1.1        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Total 17.7        
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total 203.2        
Payments to Acquire Businesses, Net of Cash Acquired   $ 193.2      
BioPhero | Developed Technology          
Finite-Lived Intangible Assets, Gross [Abstract]          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill $ 66.3        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]          
Weighted avg. useful life remaining at December 31, 2022 15 years        
BioPhero | In Process Research and Development          
Finite-Lived Intangible Assets, Gross [Abstract]          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill $ 10.5        
[1] In 2022, the purchase price of Biophero of approximately $193 million was primarily paid at closing on July 19, 2022. For additional detail on this transaction, see Note 9 to our consolidated financial statements included within this Form 10-K. The acquisitions, net amount in 2020 represents payments made on October 2, 2020 to acquire the remaining rights for Fluindapyr from Isagro S.p.A ("Isagro") in an asset acquisition.(4)During December 2022, we finalized a land transfer agreement with the Shanghai Municipal People's Government. We received cash proceeds of $50.5 million for the land transfer. For additional detail on this transaction, see Note 9 to our consolidated financial statements included within this Form 10-K.